Fragmented sleep-wake rhythm precedes Alzheimer plaques in the brain
A fragmented sleep-wake rhythm, where people often transition from rest to active during the day and night, is already visible in the brain before the accumulation of the Alzheimer’s protein amyloid-beta. That has been shown by research from Erasmus MC involving over 300 residents of the Ommoord district in Rotterdam.
Researchers break dogma: intestinal tumor does not always arise from stem cell
Scientists at Erasmus MC have discovered that intestinal tumors do not always originate from stem cells, contrary to the prevailing dogma. In the context of inflammation, specialized intestinal cells appear to be the origin of cancer.
Over 1 million euros for new form of radiation therapy
Exploring and optimizing a potential new form of radiation therapy using very high energy electrons. That is the focus of a new project by a team from the Erasmus MC Cancer Institute, TU Delft, and Lausanne University Hospital. The team has been awarded over 1 million euros from the Open Technology Programme of the Dutch […]
New generation of immune cells against breast cancer
Prof. Dr. Reno Debets, researcher within the Internal Oncology department of the Erasmus MC Cancer Institute, has received a subsidy of over 900,000 euros from KWF for his research on new immune cells for the treatment of breast cancer. The aim of the research is to create, through a public-private partnership, a new generation of […]
Scientists discover how harmful protein pimple is removed from DNA
Researchers at Erasmus MC have discovered a new mechanism to repair an important type of DNA damage. It concerns damage that manifests as a protein pimple on the DNA and likely plays a role in aging. ‘Not much research had been done on this yet.’
AI model predicts risk of skin cancer better than existing methods
Researchers at Erasmus MC have developed an artificial intelligence (AI) model that predicts the risk of skin cancer based on a photograph of the face. The AI model outperforms the current methods doctors use to assess skin cancer risk.
